The WTA will require all players to undergo genetic sex testing for the SRY gene to compete on its Tour, effective Tuesday. A negative result is needed, with positive tests leading to further medical assessment. This updates the previous policy on testosterone levels.
The WTA will implement a new eligibility policy in 2026, requiring all players to undergo genetic sex testing for the SRY gene to compete on the Tour. A negative result is needed, with positive tests leading to further medical assessment. This updates a 2024 policy on testosterone levels.
The Women's Tennis Association (WTA) is ending its partnership with Saudi Arabia for the season-ending Finals a year early, moving the tournament to Indian Wells, California. The decision, citing ongoing geopolitical tensions, comes after controversy over Saudi Arabia's human rights record.
